TABLE 2.
Effect | Chemokine Receptor | Details | Reference |
---|---|---|---|
Increased binding of chemokines | CMV US28 | Viral receptor CMV US28: Increased binding to CCL3*, CCL4†, CCL5‡, CX3CL1§ | (45) |
Increased binding of chemokines | CXCR3 | Receptor CXCR3: Increased binding to CXCL9‖, CXCL10**, CXCL11†† | (12) |
CXCR4 | Receptor CXCR4: Increased binding to CXCL12‡‡ | (9) | |
CCR2b | Receptor CCR2b: Increased binding to CCL2§§ | (10) | |
CCR5 | Receptor CCR5: Increased binding to CCL3*, CCL4†, and CCL5‡ | (5,46) | |
Increased binding to chemokine/ adhesion molecules | CX3CR1 | Receptor CX3CR1: Increased firm adhesion to CX3CL1§ | (11) |
CXCR3 | Receptor CXCR3: Increases chemotaxis after binding to CXCL9‖, CXCL10**, and CXCL11†† | (12) | |
Increased signaling/ Downstream events | CCR2b | Receptor CCR2b: Increased Ca++ influx and chemotaxis after binding to CCL2§§ | (10) |
CX3CR1 | Receptor CX3CR1: Increased Ca++ influx after binding to CXC3L1§ | (11) |
CCL3/MIP-1α
CCL4/MIP-1β
CCL5/RANTES.
CX3CL1/Fractalkine.
CXCL9/MIG.
CXCL10/IP-10.
CXCL11/I-TAC.
CXCL12/SDF-1.
CCL2/MCP-1.